Q32 BIO INC (QTTB) Stock Analyst Ratings
USA - NASDAQ:QTTB - US7469641051 - Common Stock
3.33 USD
+0.16 (+5.05%)
3.3 USD
-0.03 (-0.9%)
ChartMill assigns a Buy % Consensus number of 80% to QTTB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.2. This target is 206.31% above the current price.
QTTB was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about QTTB.
In the previous month the buy percentage consensus was at a similar level.
QTTB was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-12 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-11 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2025-02-11 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2024-12-12 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-12-12 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-12-11 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-12-11 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-12-11 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2024-12-11 | Raymond James | Downgrade | Strong Buy -> Outperform |
| 2024-12-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-12-06 | BMO Capital | Initiate | Outperform |
| 2024-10-24 | Raymond James | Initiate | Strong Buy |
| 2024-09-11 | Wells Fargo | Initiate | Overweight |
| 2024-06-17 | Guggenheim | Initiate | Buy |
| 2024-05-21 | Leerink Partners | Initiate | Outperform |
| 2024-04-11 | Oppenheimer | Initiate | Outperform |
| 2024-04-02 | Piper Sandler | Initiate | Overweight |